Lucira Health (LHDXQ) Stock Price, News & Analysis

Company Overview

Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California. On February 22, 2023, Lucira Health, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Key Stats

• Today's Range: $0.0001 to $0.0001
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $1.45
• Volume: 20,900 shs
• Average Volume: 7.18 million shs
• Market Capitalization: $4.06 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LHDXQ Stock Analysis - Frequently Asked Questions

How have LHDXQ shares performed this year?

Lucira Health's stock was trading at $0.0001 at the beginning of 2025. Since then, LHDXQ shares have increased by 0.0% and is now trading at $0.0001.
View the best growth stocks for 2025 here.

How were Lucira Health's earnings last quarter?

Lucira Health, Inc. (OTCMKTS:LHDXQ) issued its earnings results on Thursday, November, 11th. The company reported ($0.47) earnings per share for the quarter, beating analysts' consensus estimates of ($0.51) by $0.04. The firm earned $14.98 million during the quarter, compared to the consensus estimate of $18 million.

How do I buy shares of Lucira Health?

Shares of LHDXQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 11/11/2021
• Today: 6/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Diagnostic substances
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:LHDXQ
• CIK: 1652724
• Web: www.lucirahealth.com
• Phone: 510-350-8071
• Fax: N/A
• Employees: 221
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $93.06 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.81 per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 40,600,000
• Free Float: 28,257,000
• Market Cap: $4.06 thousand
• Optionable: Not Optionable
• Beta: 2.60